arrow
S

Silvia Stagni

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:21
被引数:1,354

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Active surveillance for renal masses up to 2 cm: long-term oncological outcomes from a prospective multi-institutional study

对于2厘米及以下肾肿块的主动监测:一项前瞻性多中心研究的长期肿瘤学结局

2026-04-280
PRE
Salvage post-chemotherapy retroperitoneal lymph-node dissection: evolving paradigm for marker-positive non-seminomatous germ-cell tumors management

术后化疗后腹膜后淋巴结清扫术:标志物阳性非精原细胞瘤生殖细胞瘤管理模式的演变

2026-04-090
PRE
Clinical evaluation of the role of miRNA 371 in small testicular masses. Results of the S1STeM 371 Trial

miRNA 371在小睾丸肿块中的作用临床评估。S1STeM 371试验结果

2025-06-010
PRE
Predictive value of Tmax perfusion maps on final core in acute ischemic stroke: an observational single-center study

Tmax灌注图对急性缺血性卒中最终核心的预测价值: 一项观察性单中心研究

2022-02-285
PRE
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center
2018-03-0120
PREAI
First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study

口服pan-her酪氨酸激酶抑制剂达克替尼一线治疗局部晚期或转移性阴茎鳞状细胞癌: 一项开放标签,单臂,单中心,2期研究的结果

2017-10-0469
OAAI
NEOADJUVANT SORAFENIB, GEMCITABINE, AND CISPLATIN (SGC) FOR MUSCLE-INVASIVE UROTHELIAL BLADDER CANCER (MIUBC): FINAL RESULTS AND TRANSLATIONAL FINDINGS OF AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY.
2017-04-010
PREAI
Relationship between lymph node ratio and cancer-specific survival in a contemporary series of patients with penile cancer and lymph node metastases

当代一系列阴茎癌和淋巴结转移患者的淋巴结比率与癌症特异性生存率之间的关系

2015-07-0622
PREAI
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study
2015-01-0112
OAAI